Biocryst Pharmaceuticals (BCRX) Interest Coverage Ratio (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Interest Coverage Ratio came in at 9.88 in Q1 2026, down 1193.55% YoY from 0.9 in Q1 2025, and down 153.64% on a QoQ basis from 18.42 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Interest Coverage Ratio data on file, last reported at 9.88 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 1193.55% year-over-year to 9.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.38 (down 1680.55% YoY) and the FY2025 annual result came in at 0.9, up 15912.93% from the prior year.
- Interest Coverage Ratio fell to 9.88 in Q1 2026, from 18.42 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 18.42 in Q4 2025 to a low of 9.88 in Q1 2026.
- A 5-year average of 0.18 and a median of 0.47 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio jumped 10090.73% — and 2026, when it slumped 1193.55%.
- Tracing BCRX's Interest Coverage Ratio over 5 years: stood at 1.75 in 2022, then surged by 73.24% to 0.47 in 2023, then surged by 60.64% to 0.18 in 2024, then soared by 10090.73% to 18.42 in 2025, then tumbled by 153.64% to 9.88 in 2026.
- The last three Interest Coverage Ratio figures came in at 9.88 (Q1 2026), 18.42 (Q4 2025), and 1.02 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 4.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 |
| Mar 31, 2026 | -9.88 |
| Dec 31, 2025 | 18.42 |
| Sep 30, 2025 | 1.02 |
| Jun 30, 2025 | 1.38 |
| Mar 31, 2025 | 0.90 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.35 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.44 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -1.04 |
| Dec 31, 2022 | -1.75 |
| Sep 30, 2022 | -0.70 |
| Jun 30, 2022 | -1.45 |
| Mar 31, 2022 | -2.10 |
| Dec 31, 2021 | -2.78 |
| Sep 30, 2021 | -3.16 |